Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Windlas Biotech Ltd. ( (IN:WINDLAS) ) has issued an update.
Windlas Biotech Ltd. has announced a scheduled meeting with investors and analysts on March 17, 2025, which will be conducted virtually. This meeting is part of the company’s ongoing efforts to maintain transparency and engage with stakeholders, potentially impacting its market perception and investor relations.
More about Windlas Biotech Ltd.
Windlas Biotech Ltd. operates in the pharmaceutical industry, focusing on the manufacturing and development of pharmaceutical formulations. The company is involved in the production of a wide range of products, catering to various therapeutic segments, and aims to serve both domestic and international markets.
YTD Price Performance: -10.38%
Average Trading Volume: 6,567
Current Market Cap: 19.68B INR
For an in-depth examination of WINDLAS stock, go to TipRanks’ Stock Analysis page.